#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Juvenile psoriatic arthritis Chronic myeloid leukaemia (in remission) Acute respiratory distress syndrome Macular telangiectasia Adrenogenital syndrome Chronic kidney disease Thromboangiitis obliterans Bronchiolitis Familial dilated cardiomyopathy Pyruvate dehydrogenase complex deficiency Cardiac arrest Measles Piriformis syndrome Interstitial lung disease Paraganglion neoplasm More trials…

    Learn about Rare Diseases

    Hereditary neuropathic amyloidosis – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Skin angiosarcoma – Diagnostics Friedreich’s ataxia – Treatment Biotinidase deficiency – Treatment Advanced systemic mastocytosis – Diagnostics Rett syndrome – Treatment Hairy cell leukaemia recurrent Burkitt’s lymphoma – Treatment Antithrombin III deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    XENON (133XE) Felis Domesticus (555) Fulvestrant Zalunfiban Maridebart Cafraglutide Intestifix Zilucoplan Sodium Regtivex Oxaliplatin Eltrombopag GSKVX000000048111 Disitamab Vedotin ALXN2420 Nanatinostat VTX-002 Ifosfamide Lucerastat Dexchlorpheniramine Alpelisib Levobupivacaine Hydrochloride More therapies…

    Learn about Your Condition

    Spina bifida Lupus nephritis Head injury Alagille syndrome Myelodysplastic syndrome Oesophageal disorder Trisomy 21 Athetosis Mucopolysaccharidosis III Anal cancer stage II Malignant melanoma Systemic sclerosis pulmonary Langerhans cell sarcoma Aortic valve stenosis Body mass index increased More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Partial seizures

  • Safety and tolerability of OV329 as add‑on therapy in adults with drug‑resistant focal epilepsy

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Partial seizures
    The Netherlands

  • A study to evaluate the effectiveness and safety of vormatrigine in adults with focal epilepsy who are taking one to three anti-seizure medications.

    Not yet recruiting

    3 1
    Investigated Drugs:
    • VORMATRIGINE
    Czechia Germany Italy Poland Spain

  • Study of Probenecid for Controlling Cluster Seizures in Patients with Focal Epilepsy During Pre-surgical Video-EEG Monitoring

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Partial seizures
    France

  • Study of Cenobamate for Children with Partial-Onset Seizures

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • Cenobamate
    Hungary Spain

  • Study on PRAX-628 for Adults with Focal Onset or Generalized Tonic-Clonic Seizures

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Generalised tonic-clonic seizure
    • Partial seizures
    Investigated Drugs:
    • Prax-628
    Germany Spain

  • Study on the Safety and Effectiveness of Azetukalner for Adults with Focal Epilepsy Taking 1 to 3 Anti-Seizure Medications

    Not recruiting

    2 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • Azetukalner
    Germany Italy Spain
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!